ID | 110753 |
Author |
Shimada, Mitsuo
Department of Digestive and Pediatric Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Fujii, Masahiko
Department of Digestive and Pediatric Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School
Morine, Yuji
Department of Digestive and Pediatric Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Imura, Satoru
Department of Digestive and Pediatric Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School
KAKEN Search Researchers
Ikemoto, Tetsuya
Department of Digestive and Pediatric Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
Ishibashi, Hiroki
Department of Digestive and Pediatric Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
|
Keywords | Adult-to-adult living donor liver transplantation
small-for-size graft
large-for-size graft
hepatocellular carcinoma
ABO blood-type incompatible transplantation
marginal donor
hepatitis C
fatty liver
age
|
Content Type |
Journal Article
|
Description | About 15 years have passed since the first liver transplant from a living donor (living donor liver transplantation : LDLT), and the status of the procedure has since been established as a standard cure for end-stage liver disease in Japan where liver transplantation (LTx) from deceased donors has not yet been accepted. However, the following problems are surfacing with the increase in the number of LDLTs between adults : graft size mismatching, an ABO blood-type incompatible transplantation, the expansion of LDLT indication to hepatocellular carcinoma (HCC), the relapse of hepatitis C after LDLT, marginal donors, and the freedom from immunosuppressive treatment. In this article we outline the present conditions of these problems and the future view of the LDLT.
|
Journal Title |
The journal of medical investigation : JMI
|
ISSN | 13431420
|
NCID | AA11166929
|
Volume | 52
|
Issue | 1-2
|
Start Page | 22
|
End Page | 32
|
Sort Key | 22
|
Published Date | 2005-02
|
EDB ID | |
DOI (Published Version) | |
URL ( Publisher's Version ) | |
FullText File | |
language |
eng
|
TextVersion |
Publisher
|
departments |
Medical Sciences
University Hospital
|